Levofloxacin Baxter

Levofloxacin, the active ingredient in Levofloxacin Baxter, is a fluoroquinolone antibiotic presented as an injection for intravenous use. It treats a range of serious bacterial infections in adults, including community‑acquired pneumonia, complicated urinary tract infections, intra‑abdominal infections, and skin and soft‑tissue infections.

GNH USA supplies Levofloxacin Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levofloxacin is a fluoroquinolone antibiotic used intravenously to treat serious bacterial infections.

- Community‑acquired bacterial pneumonia: provides rapid bacterial clearance and clinical improvement in adult patients. - Complicated urinary tract infections: eradicates uropathogens resistant to other agents, supporting resolution of infection. - Complicated intra‑abdominal infections: targets mixed aerobic and anaerobic organisms, aiding recovery after surgical or medical management. - Skin and soft‑tissue infections: eliminates common Gram‑positive and Gram‑negative pathogens, facilitating healing.

Levofloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset occurring in many patients. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Rash: mild skin erythema or itching. - Elevated liver enzymes: mild, asymptomatic transaminase rise.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles, may occur without warning. - QT interval prolongation: can lead to cardiac arrhythmias. - Severe hypersensitivity reactions: including Stevens‑Johnson syndrome. - Clostridioides difficile infection: colitis following disruption of gut flora. - Central nervous system effects: seizures or confusion in susceptible individuals.

Before using Levofloxacin, clinicians should consider several safety precautions. - Renal impairment: adjust therapy and monitor renal function. - Hepatic dysfunction: use with caution in patients with liver disease. - History of tendon disorders: avoid in patients with prior tendonitis or rupture. - Cardiac risk: assess QT prolongation risk, especially with other QT‑prolonging drugs. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacin can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption; separate administration by at least 2 hours. - Warfarin: may increase INR and bleeding risk; monitor coagulation parameters closely. - Cyclosporine: increased risk of nephrotoxicity; consider dose adjustment.

Moderate Interactions (Monitor Closely): - NSAIDs (e.g., ibuprofen): may increase risk of CNS stimulation or seizures. - Theophylline: levofloxacin can raise plasma theophylline levels; monitor for toxicity. - Diabetic agents (e.g., insulin, sulfonylureas): may cause hypoglycemia; monitor blood glucose.